Safe Re-administration of Tumor Necrosis Factor-alpha (TNFα) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFα Therapy

There is no consensus on whether it is safe to re-administer tumor necrosis factor-alpha (TNFα) inhibitors in patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) flared after withdrawal of TNFα inhibitors due to active tuberculosis (TB). We evaluated the safety of restarting anti-...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Suh, Young Sun, Kwok, Seung-ki, Ju, Ji Hyeon, Park, Kyung-Su, Park, Sung-Hwan, Yoon, Chong-Hyeon
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Korean Academy of Medical Sciences 2014
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3890474/
https://ncbi.nlm.nih.gov/pubmed/24431903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2014.29.1.38
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi